CFLAR and lung cancer: Moreover, a study shows that the overexpression of PRMT5 increased expression of c-FLIPL by decreasing the ubiquitination via inhibition of the interaction between c-FLIPL and ITCH, leading to decreased apoptotic cells induced by doxorubicin in human lung cancer cells[118].